Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_assertion type Assertion NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_head.
- NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_assertion description "[The ERCC2 genotype appears as an important predictive factor of the survival of patients treated with oxaliplatin in first-line therapy for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_provenance.
- NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_assertion evidence source_evidence_literature NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_provenance.
- NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_assertion SIO_000772 18085999 NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_provenance.
- NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_assertion wasDerivedFrom befree-20140225 NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_provenance.
- NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_assertion wasGeneratedBy ECO_0000203 NP773492.RANdV5c8ZbqfSxJbe5ZFtYgk0UnefOBdh7lJ2HVBuoVXA130_provenance.